Shilpa Medicare is currently trading at Rs. 592.00, down by 6.80 points or 1.14% from its previous closing of Rs. 598.80 on the BSE.
The scrip opened at Rs. 605.00 and has touched a high and low of Rs. 605.00 and Rs. 592.00 respectively. So far 1,337 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 748.95 on 12-Apr-2017 and a 52 week low of Rs. 537.10 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 605.00 and Rs. 573.00 respectively. The current market cap of the company is Rs. 4,743.00 crore.
The promoters holding in the company stood at 53.80%, while Institutions and Non-Institutions held 31.79% and 14.40% respectively.
Shilpa Medicare has received three 483 observations from the United States Food & Drug Administration (USFDA) for its API facility located at Raichur. The USFDA has completed inspection of company’s API facilities Unit-I and Unit-II located at Raichur, Karnataka, India which was inspected between January 16 and January 19, 2018.
The inspection has now been closed by the USFDA with three 483 observations. The company is in the process of submission of corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines in response to the form 483 issued at the end of inspection.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1536.95 |
Dr. Reddys Lab | 6038.00 |
Cipla | 1384.30 |
Zydus Lifesciences | 937.80 |
Lupin | 1613.90 |
View more.. |